Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Suppressing certain hormones might help prevent prostate cancer.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Some blood pressure medications are linked to a higher risk of skin cancer.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.